During the Forbes Healthcare Summit 2013, Chairman and Editor-in-Chief Steve Forbes talks with Sir Andrew Witty, CEO GlaxoSmithkline, about how the pharma industry is leveraging big data. Traditionally, big pharma kept their data and results under lock and key. Now, with a global population impatient to find answers and cures, the industry is working together to affect change.
Big Pharma Collaborating On Big Data To Save The World
